198 related articles for article (PubMed ID: 2465574)
21. Novel investigative approaches for advanced renal cell carcinoma.
Berg WJ; Divgi CR; Nanus DM; Motzer RJ
Semin Oncol; 2000 Apr; 27(2):234-9. PubMed ID: 10768602
[TBL] [Abstract][Full Text] [Related]
22. C-reactive protein: a biomarker of survival in patients with metastatic renal cell carcinoma treated with subcutaneous interleukin-2 based immunotherapy.
Casamassima A; Picciariello M; Quaranta M; Berardino R; Ranieri C; Paradiso A; Lorusso V; Guida M
J Urol; 2005 Jan; 173(1):52-5. PubMed ID: 15592024
[TBL] [Abstract][Full Text] [Related]
23. [Guideline 'Renal cell carcinoma'].
Mulders PF; Brouwers AH; Hulsbergen-van der Kaa CA; van Lin EN; Osanto S; de Mulder PH
Ned Tijdschr Geneeskd; 2008 Feb; 152(7):376-80. PubMed ID: 18380384
[TBL] [Abstract][Full Text] [Related]
24. Systemic therapy of metastatic renal cell carcinoma.
Vugrin D
Semin Nephrol; 1987 Jun; 7(2):152-62. PubMed ID: 2442806
[No Abstract] [Full Text] [Related]
25. Adjuvant therapy for renal cell carcinoma.
Jacobsohn KM; Wood CG
Semin Oncol; 2006 Oct; 33(5):576-82. PubMed ID: 17045086
[TBL] [Abstract][Full Text] [Related]
26. Multimodality treatment of metastatic renal cell carcinoma.
Mickisch GH
Expert Rev Anticancer Ther; 2002 Dec; 2(6):681-5. PubMed ID: 12503214
[TBL] [Abstract][Full Text] [Related]
27. [Outcome of patients in metastatic renal cell carcinoma with or without embolization].
Masuda F; Nakada J; Takasaka S; Hishinuma H
Hinyokika Kiyo; 1987 Sep; 33(9):1354-6. PubMed ID: 3434491
[TBL] [Abstract][Full Text] [Related]
28. Renal cell carcinoma: new developments in molecular biology and potential for targeted therapies.
Costa LJ; Drabkin HA
Oncologist; 2007 Dec; 12(12):1404-15. PubMed ID: 18165617
[TBL] [Abstract][Full Text] [Related]
29. [Immunology in clinical practice. XVII. Immunotherapy of metastatic renal cell carcinoma. Work Group Immunotherapy, Dutch Oncology].
van Herpen CM; de Mulder PH
Ned Tijdschr Geneeskd; 1998 Nov; 142(48):2613-8. PubMed ID: 10028361
[TBL] [Abstract][Full Text] [Related]
30. New treatments for metastatic kidney cancer.
Mancuso A; Sternberg CN
Can J Urol; 2005 Feb; 12 Suppl 1():66-70; discussion 105. PubMed ID: 15780170
[TBL] [Abstract][Full Text] [Related]
31. Role of cytokine therapy in 2006 and beyond for metastatic renal cell cancer.
Parton M; Gore M; Eisen T
J Clin Oncol; 2006 Dec; 24(35):5584-92. PubMed ID: 17158544
[TBL] [Abstract][Full Text] [Related]
32. Metastatic renal cell carcinoma: many treatment options, one patient.
Rini BI
J Clin Oncol; 2009 Jul; 27(19):3225-34. PubMed ID: 19470934
[TBL] [Abstract][Full Text] [Related]
33. [The medical treatment of renal cancer in adults].
Sculier JP
Rev Med Brux; 1989 May; 10(5):190-6. PubMed ID: 2662317
[TBL] [Abstract][Full Text] [Related]
34. Nephrectomy and interleukin-2 for metastatic renal-cell carcinoma.
Pantuck AJ; Belldegrun AS; Figlin RA
N Engl J Med; 2001 Dec; 345(23):1711-2. PubMed ID: 11759660
[No Abstract] [Full Text] [Related]
35. [Long-term results of endovascular treatment of metastatic renal cell cancer].
Granov AM; Gorelov AI; Shumskiĭ IA; Polikarpov AA; Shkol'nik MI; Vorob'ev MI; Karelin MI
Vestn Rentgenol Radiol; 1999; (6):20-3. PubMed ID: 10714226
[TBL] [Abstract][Full Text] [Related]
36. Current clinical practice of induction and maintenance immunotherapy for metastatic renal cell carcinoma.
Little B; Young M; Ho KJ
Int J Clin Pract; 2002; 56(1):36-9. PubMed ID: 11831831
[TBL] [Abstract][Full Text] [Related]
37. Targeted therapy for renal cell carcinoma: a new therapeutic paradigm.
Shaheen PE; Bukowski RM
Cancer Invest; 2006 Oct; 24(6):640-56. PubMed ID: 16982470
[TBL] [Abstract][Full Text] [Related]
38. Multimodality treatment paradigms for renal cell carcinoma: surgery versus targeted agents.
Köpke T; Bierer S; Wülfing C; Tiemann A; Hertle L; Herrmann E
Expert Rev Anticancer Ther; 2009 Jun; 9(6):763-71. PubMed ID: 19496713
[TBL] [Abstract][Full Text] [Related]
39. [Interleukin 2 based ambulatory therapy of metastatic renal cell carcinoma].
Atzpodien J; Kirchner H; Poliwoda H
Med Klin (Munich); 1996 Apr; 91 Suppl 3():38-43. PubMed ID: 8692118
[TBL] [Abstract][Full Text] [Related]
40. Neoadjuvant (presurgical) therapy for renal cell carcinoma: a new treatment paradigm for locally advanced and metastatic disease.
Wood CG; Margulis V
Cancer; 2009 May; 115(10 Suppl):2355-60. PubMed ID: 19402066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]